When the implanted device is activated, the men can wiggle their toes, lift their legs and stand briefly. But they aren't able to walk and still use wheelchairs to get around.
While only a handful of patients have received the British lab-made organs so far, researchers hope they will soon be able to transplant more types of body parts into patients, including what would be the world's first nose made partly from stem cells.
The nation's disease detectives are beginning a program to try to outsmart outbreaks by routinely decoding the DNA of potentially deadly bacteria and viruses.
Scientists have created a detailed, three-dimensional wiring diagram of the mouse brain. That should help researchers seek clues about how the human brain works in health and disease.
Johnson & Johnson has accepted an offer of about $4 billion from the private equity firm The Carlyle Group to buy its Ortho-Clinical Diagnostics business.
Survival rates were better one year later for people who had a new valve placed through a tube into an artery instead.
Lawyers and advocates for women alleging Johnson & Johnson products injured them urged the U.S. Justice Department on Wednesday to investigate their claims the health care giant deliberately destroyed many documents critical to their lawsuits.
Dr. Glenn Green and Scott Hollister came up with the solution to save a young boy's life: use 3D printing to build small splints that would help keep his trachea open until it was strong enough to do so itself.
IBM and its Watson cloud computing system are partnering with the New York Genome Center to help it sequence DNA for the treatment of brain cancer.
Renal services provider Fresenius Medical Care has announced it will locate its East Coast manufacturing facility in Knoxville, creating 665 jobs in the coming years.
The Food and Drug Administration said Tuesday it approved a nerve-stimulating headband as the first medical device to prevent migraine headaches.
Scientists have modified genes in the blood cells of HIV patients to help them resist the AIDS virus, and say the treatment seems safe and promising.
Dr. Michael Heggeness is working on a $1.6 million research product — a "bone putty" — that could be a viable alternative to typical treatment options for combat-related trauma issues.
Check out some of this week's top headlines from across Manufacturing.net, from a phone that can self-destruct from an airplane manufacturer to more stress for Detroit from the United Auto Workers union.
In a report published Tuesday, House Republicans say the FDA's computer surveillance may have overstepped federal laws designed to protect government whistleblowers. Using software that took rapid fire screen shots of employees' computers, the FDA picked up emails from the five whistleblowers to members of Congress.
Maybe we can transport patients with hover-stretchers and flying ambulances, too. Announcements like this are bound to raise a few eyebrows, but we live in a world where 3D-printed hearts and other highly advanced surgical procedures are slowly becoming commonplace.
A federal judge has ruled in favor of a manufacturer in a lawsuit brought by a Texas woman who claimed her pelvic pain was caused by implanted surgical mesh. U.S. District Judge Joseph R. Goodwin on Tuesday dismissed Carolyn Lewis' lawsuit against Johnson & Johnson subsidiary Ethicon in the middle of a jury trial that began Feb. 10.
European researchers have taken a step toward prosthetics with a sense of touch: They created a robotic hand that let an amputee feel differences in the shape and hardness of different objects, and adjust his grasp in response.
A kinder, gentler approach to one of the most dreaded exams in medicine is on the way: U.S. regulators have cleared a bite-size camera to help screen patients who have trouble with colonoscopies. The ingestible pill camera from Given Imaging is designed to help doctors spot polyps and other early signs of colon cancer.
About 20 percent of the studies were not completed for reasons that had nothing to do with the treatment's safety or effectiveness, both legitimate reasons for ending a study early. Poor accrual — the inability to enroll enough patients in enough time to finish the study — led to nearly 40 percent of premature endings.
Forget being sneezed on: Government scientists are deliberately giving dozens of volunteers the flu by squirting the live virus straight up their noses. It may sound bizarre, but the rare type of research is a step in the quest for better flu vaccines. It turns out that how the body fends off influenza remains something of a mystery.
In a news release, Tennessee Economic and Community Development Commissioner Bill Hagerty says the company will invest $25 million in manufacturing equipment and building and infrastructure improvements in Morristown.
The National Newspaper Publishers Association and National Association of Black Owned Broadcasters argued that the ads should be disseminated through their outlets because the black community has been disproportionally targeted by tobacco companies and harmed by smoking.
Did you ever wonder who is involved in the creation and promulgation of these standards? Most people have no idea – and it’s an incredibly important piece of business intelligence to have, since those at the table where standards are developed have the opportunity to shape the specifications and market acceptance of products and systems for every industry.
The laboratory test from Affymetrix detects variations in patients' chromosomes that are linked to Down syndrome, DiGeorge syndrome and other developmental disorders. About 2 to 3 percent of U.S. children have some sort of intellectual disability, according to the National Institutes of Health.